Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe

Anne-Marie Miller, Mircea Balasa, Kaj Blennow, Mary Gardiner, Aleksandra Rutkowska, Philip Scheltens, Charlotte E. Teunissen, Pieter Jelle Visser, Bengt Winblad, Gunhild Waldemar, Brian Lawlor*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)201-210
Number of pages10
JournalJournal of Alzheimer's Disease
Volume60
Issue number1
DOIs
Publication statusPublished - 2017

Keywords

  • Alzheimer's disease
  • attitudes
  • biomarkers
  • cerebrospinal fluid
  • dementia
  • ALZHEIMERS ASSOCIATION WORKGROUPS
  • MILD COGNITIVE IMPAIRMENT
  • NINCDS-ADRDA CRITERIA
  • NATIONAL INSTITUTE
  • DISEASE DIAGNOSIS
  • CONSENSUS PAPER
  • CSF BIOMARKERS
  • STANDARDIZATION
  • RECOMMENDATIONS
  • GUIDELINES

Cite this